Sickle Cell Disease (SCD): Clinical Trials

4 trials for Sickle Cell Disease (SCD), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed, 1 not yet recruiting. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Recruiting 2, Completed 1, Not yet recruiting 1

Follow Sickle Cell Disease (SCD): new trials by email Literature Review of Sickle Cell Disease (SCD) trials Research Report on Sickle Cell Disease (SCD)

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Low Dose Bolus Ketamine For Use In Sickle Cell Pain Crisis
Standardized Low-dose bolus IV Ketamine within 30 minutes of arrival and every 1 hour as needed for max of 3 doses., Standard Care (in control arm) - Vaso-Occlusive Pain Episode in Sickle Cell Disease, Sickle Cell Disease (SCD)
Phase 4Not yet recruitingUniversity of Mississippi Medical Center4002026-08-012026-07-06
Integrating Point of Care Testing (POCT) For Newborn Screening and Early Care for Sickle Cell Disease in Yopougon, Côte d'Ivoire
Gazelle-Multispectral point of care testing for newborn sickle cell disease screening; and initiation of early comprehensive clinical interventions - Sickle Cell Disease (SCD)
Phase 4RecruitingSwiss Tropical & Public Health Institute1202026-07-272026-10-05
Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease
Depot medroxyprogesterone acetate (DMPA) - Sickle Cell Disease (SCD), Vaso-Occlusive Pain Episode in Sickle Cell Disease
Phase 4RecruitingUniversity of Pennsylvania652025-06-262026-11-05
An Indian Multi-centric Phase IV Study to Assess the Safety of Crizanlizumab in Sickle Cell Disease Patients
crizanlizumab - Sickle Cell Disease (SCD)
Phase 4CompletedNovartis Pharmaceuticals1402021-07-142025-09-26

Narrower conditions

Anemia, Sickle Cell (4)  ·  Hemoglobin SC Disease (1)  ·  Vaso-Occlusive Crises (1)

Broader conditions

Anemia (4)  ·  Anemia, Hemolytic (4)  ·  Anemia, Hemolytic, Congenital (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Genetic Diseases, Inborn (4)  ·  Hematologic Diseases (4)  ·  Hemic and Lymphatic Diseases (4)  ·  Hemoglobinopathies (4)

Interventions

Health Services Needs and Demand (1)  ·  Standard of Care (1)  ·  crizanlizumab (1)

Sponsors

Novartis Pharmaceuticals (1)  ·  Swiss Tropical & Public Health Institute (1)  ·  University of Mississippi Medical Center (1)  ·  University of Pennsylvania (1)

Countries

United States (2)  ·  Côte d’Ivoire (1)  ·  India (1)

Top investigators

Andrea Roe, MD MPH (1)  ·  John N Freeman, MD (1)

NIH funding

R01HL175726 (1)